BOSTON, April 30, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in AI-powered pathology solutions, today announced it will present research from the outputs of IBD Explore TM and AIM-HI UC TM at ...
BOSTON, March 24, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in AI-powered pathology, is pleased to announce that Annapath Pathology Services, Inc., Peninsula Pathology Medical Group (PPMG), ...
First-of-its-kind digital pathology network powered by PathAI’s AISight® platform expands access to latest AI products, unlocks real-world data value, and fuels collaborative research with biopharma ...
BOSTON, Nov. 18, 2025 (GLOBE NEWSWIRE) -- PathAI, a leader in AI-powered pathology, today announced that PathExplore™ 1 is now available on the AISight® 2 Image Management System (IMS) with early ...
The University Hospital Zurich (USZ) is one of Europe’s leading academic medical centers, offering cutting-edge clinical care and internationally recognized diagnostic expertise. The Department of ...
BOSTON, June 24, 2021 /PRNewswire/ -- PathAI, a global provider of AI-powered technology applied to pathology, today announced the presentation of new data describing improved digital assessment of ...
SECAUCUS, N.J. and BOSTON, May 7, 2024 /CSRwire/ - Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, and PathAI, a global provider of artificial intelligence-powered ...
Quest Diagnostics completed its previously announced acquisition of key assets from Boston biotech PathAI Diagnostics. In a June 11 press release, the Secaucus-based testing provider announced the ...
Why a Tech Power Player? For being a leader in AI-powered medical diagnostics. Dr. Andrew Beck is a Brown University-trained pathologist who did his residency at Stanford University and then stuck ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback